A new rapidly absorbed paediatric paracetamol suspension. A six-way crossover pharmacokinetic study comparingthe rate and extent of paracetamol absorption from a new paracetamol suspension with two marketed paediatric formulations

By Smith Stephen   Collaku Agron   Heaslip Louise   Yue Yong   Starkey Yan-Yan   Clarke Geoffrey   Kronfeld Nick  

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 3, 2012-03 ,pp. : 372-379

Informa Healthcare

Access to resources Recommend Favorite

A Comparison of Physicochemical Property Profiles of Marketed Oral Drugs and Orally Bioavailable Anti-Cancer Protein Kinase Inhibitors in Clinical Development

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 14, 2007-07 ,pp. : 1408-1422

Bentham Science Publishers

Access to resources Recommend Favorite

A Comparative Study of the CYP450 Inhibition Potential of Marketed Drugs Using Two Fluorescence Based Assay Platforms Routinely Used in the Pharmaceutical Industry

By  

Drug Metabolism Letters, Vol. 5, Iss. 1, 2011-01 ,pp. : 30-39

Bentham Science Publishers

Access to resources Recommend Favorite

Characterizing early prescribers of newly marketed drugs in Canada: a population-based study

By Kozyrskyj Anita   Raymond Colette   Racher Amber  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 6, 2007-06 ,pp. : 597-604

Springer Publishing Company

Access to resources Recommend Favorite

Selection of 12‐Hour Sustained‐Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained‐Release Prototype Formulations and Standard Acetaminophen Formulation: An Open‐Label, Randomized, Proof‐of‐Principle Pharmacokinetic Study

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 87-94

John Wiley & Sons Inc

Access to resources Recommend Favorite